1-12 of 12
Charles M. Alexander
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors

Thomas Danne, Satish Garg, Anne L. Peters, John B. Buse, Chantal Mathieu, Jeremy H. Pettus, Charles M. Alexander, Tadej Battelino, F. Javier Ampudia-Blasco, Bruce W. Bode, Bertrand Cariou, Kelly L. Close, Paresh Dandona, Sanjoy Dutta, Ele Ferrannini, Spiros Fourlanos, George Grunberger, Simon R. Heller, Robert R. Henry, Martin J. Kurian, Jake A. Kushner, Tal Oron, Christopher G. Parkin, Thomas R. Pieber, Helena W. Rodbard, Desmond Schatz, Jay S. Skyler, William V. Tamborlane, Koutaro Yokote, Moshe Phillip
Journal: Diabetes Care
Diabetes Care 2019;42(6):1147–1154
https://doi.org/10.2337/dc18-2316
Published: 06 February 2019
View article titled, International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors
Open the PDF for International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors in another window
Includes: Supplementary data
Journal Articles

Comment on Monnier et al. Magnitude of the Dawn Phenomenon and Its Impact on the Overall Glucose Exposure in Type 2 Diabetes: Is This of Concern? Diabetes Care 2013;36:4057–4062

Richard D. Carr, Charles M. Alexander
Journal: Diabetes Care
Diabetes Care 2014;37(7):e161–e162
https://doi.org/10.2337/dc14-0352
Published: 12 June 2014
View article titled, Comment on Monnier et al. Magnitude of the Dawn Phenomenon and Its Impact on the Overall Glucose Exposure in Type 2 Diabetes: Is This of Concern? Diabetes Care 2013;36:4057–4062
Open the PDF for Comment on Monnier et al. Magnitude of the Dawn Phenomenon and Its Impact on the Overall Glucose Exposure in Type 2 Diabetes: Is This of Concern? Diabetes Care 2013;36:4057–4062 in another window
Journal Articles

Treatment Escalation and Rise in HbA1c Following Successful Initial Metformin Therapy

Gregory A. Nichols, PHD, Charles M. Alexander, MD, Cynthia J. Girman, DRPH, Sachin J. Kamal-Bahl, PHD, Jonathan B. Brown, MPP, PHD
Journal: Diabetes Care
Diabetes Care 2006;29(3):504–509
https://doi.org/10.2337/diacare.29.03.06.dc05-1937
Published: 01 March 2006
View article titled, Treatment Escalation and Rise in HbA<sub>1c</sub> Following Successful Initial Metformin Therapy
Open the PDF for Treatment Escalation and Rise in HbA<sub>1c</sub> Following Successful Initial Metformin Therapy in another window
Journal Articles

Glycemic Control Continues to Deteriorate After Sulfonylureas Are Added to Metformin Among Patients With Type 2 Diabetes

Michael N. Cook, PHD, Cynthia J. Girman, DRPH, Peter P. Stein, MD, Charles M. Alexander, MD, Rury R. Holman, MD
Journal: Diabetes Care
Diabetes Care 2005;28(5):995–1000
https://doi.org/10.2337/diacare.28.5.995
Published: 01 May 2005
View article titled, Glycemic Control Continues to Deteriorate After Sulfonylureas Are Added to Metformin Among Patients With Type 2 Diabetes
Open the PDF for Glycemic Control Continues to Deteriorate After Sulfonylureas Are Added to Metformin Among Patients With Type 2 Diabetes in another window
Journal Articles

End-Stage Renal Disease-Associated Managed Care Costs Among Patients With and Without Diabetes

Amie T. Joyce, MPH, John M. Iacoviello, PHD, Soma Nag, PHD, Shiva Sajjan, PHD, Evguenia Jilinskaia, PHD, Diane Throop, MS, Alexander Pedan, PHD, Daniel A. Ollendorf, MPH, Charles M. Alexander, MD
Journal: Diabetes Care
Diabetes Care 2004;27(12):2829–2835
https://doi.org/10.2337/diacare.27.12.2829
Published: 01 December 2004
View article titled, End-Stage Renal Disease-Associated Managed Care Costs Among Patients With and Without Diabetes
Open the PDF for End-Stage Renal Disease-Associated Managed Care Costs Among Patients With and Without Diabetes in another window
Journal Articles

The Metabolic Syndrome: The Emperor Needs Some Consistent Clothes : Response to Vinicor and Bowman

Charles M. Alexander, MD
Journal: Diabetes Care
Diabetes Care 2004;27(5):1244
https://doi.org/10.2337/diacare.27.5.1244
Published: 01 May 2004
View article titled, The Metabolic Syndrome: The Emperor Needs Some Consistent Clothes : <subtitle>Response to Vinicor and Bowman</subtitle>
Open the PDF for The Metabolic Syndrome: The Emperor Needs Some Consistent Clothes : <subtitle>Response to Vinicor and Bowman</subtitle> in another window
Journal Articles

Adequacy of Glycemic, Lipid, and Blood Pressure Management for Patients With Diabetes in a Managed Care Setting

Sarah J. Beaton, PHD, Soma S. Nag, PHD, Margaret J. Gunter, PHD, Jeremy M. Gleeson, MD, Shiva S. Sajjan, PHD, Charles M. Alexander, MD
Journal: Diabetes Care
Diabetes Care 2004;27(3):694–698
https://doi.org/10.2337/diacare.27.3.694
Published: 01 March 2004
View article titled, Adequacy of Glycemic, Lipid, and Blood Pressure Management for Patients With Diabetes in a Managed Care Setting
Open the PDF for Adequacy of Glycemic, Lipid, and Blood Pressure Management for Patients With Diabetes in a Managed Care Setting in another window
Journal Articles

Lowering the Criterion for Impaired Fasting Glucose Will Not Provide Clinical Benefit

Mayer B. Davidson, MD, Pamela B. Landsman, MPH, Charles M. Alexander, MD
Journal: Diabetes Care
Diabetes Care 2003;26(12):3329–3330
https://doi.org/10.2337/diacare.26.12.3329
Published: 01 December 2003
View article titled, Lowering the Criterion for Impaired Fasting Glucose Will Not Provide Clinical Benefit
Open the PDF for Lowering the Criterion for Impaired Fasting Glucose Will Not Provide Clinical Benefit in another window
Journal Articles

The Coming of Age of the Metabolic Syndrome

Charles M. Alexander, MD
Journal: Diabetes Care
Diabetes Care 2003;26(11):3180–3181
https://doi.org/10.2337/diacare.26.11.3180
Published: 01 November 2003
View article titled, The Coming of Age of the Metabolic Syndrome
Open the PDF for The Coming of Age of the Metabolic Syndrome in another window
Journal Articles

Trends in Lipid Management Among Patients With Coronary Artery Disease: Has diabetes received the attention it deserves?

Mark W. Massing, MD, PHD, Kathleen A. Foley, PHD, Carla A. Sueta, MD, PHD, Mridul Chowdhury, PHD, David P. Biggs, BS, Charles M. Alexander, MD, Ross J. Simpson, Jr., MD, PHD
Journal: Diabetes Care
Diabetes Care 2003;26(4):991–997
https://doi.org/10.2337/diacare.26.4.991
Published: 01 April 2003
View article titled, Trends in Lipid Management Among Patients With Coronary Artery Disease: <subtitle>Has diabetes received the attention it deserves?</subtitle>
Open the PDF for Trends in Lipid Management Among Patients With Coronary Artery Disease: <subtitle>Has diabetes received the attention it deserves?</subtitle> in another window
Journal Articles

Losartan Reduces the Costs Associated With Diabetic End-Stage Renal Disease: The RENAAL study economic evaluation

William H. Herman, MD, MPH, Shahnaz Shahinfar, MD, George W. Carides, PHD, Erik J. Dasbach, PHD, William C. Gerth, MBA, Charles M. Alexander, MD, John R. Cook, PHD, William F. Keane, MD, Barry M. Brenner, MD, For the RENAAL Investigators
Journal: Diabetes Care
Diabetes Care 2003;26(3):683–687
https://doi.org/10.2337/diacare.26.3.683
Published: 01 March 2003
View article titled, Losartan Reduces the Costs Associated With Diabetic End-Stage Renal Disease: <subtitle>The RENAAL study economic evaluation</subtitle>
Open the PDF for Losartan Reduces the Costs Associated With Diabetic End-Stage Renal Disease: <subtitle>The RENAAL study economic evaluation</subtitle> in another window
Journal Articles

How Cost-Effective Is the Treatment of Dyslipidemia in Patients With Diabetes but Without Cardiovascular Disease?

Steven A. Grover, MD, MPA, FRCPC, Louis Coupal, MSC, Hanna Zowall, MSC, Charles M. Alexander, MD, FACP, FACE, Thomas W. Weiss, DRPH, Daniel R.J. Gomes, MSC
Journal: Diabetes Care
Diabetes Care 2001;24(1):45–50
https://doi.org/10.2337/diacare.24.1.45
Published: 01 January 2001
View article titled, How Cost-Effective Is the Treatment of Dyslipidemia in Patients With Diabetes but Without Cardiovascular Disease?
Open the PDF for How Cost-Effective Is the Treatment of Dyslipidemia in Patients With Diabetes but Without Cardiovascular Disease? in another window